Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia

Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03300557	Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer	completed	Phase 2	40	National Cancer Institute (NCI)NIH	1	Aug 29, 2025	clinicaltrials
NCT00483327	Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate	completed	Phase 2	31	NYU Langone HealthOTHER	1	Apr 4, 2018	clinicaltrials